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Abstract
Background: Acupressure therapy may be potentially beneficial in improving postoperative symptoms like
postoperative nausea and vomiting (PONV), pain and sleep disorder and improving postoperative quality of
recovery. The primary aim of this study is to investigate the efficacy of acupressure therapy on postoperative
patient satisfaction and quality of recovery in hospitalized patients after surgical treatment.
Methods/design: This three-group, parallel, superiority, blinded, randomized controlled trial will test the hypothesis
that a combination of PC6, LI4 and HT7 acupressure is superior to sham or no intervention for improving postoperative
quality of recovery in hospitalized patients. A minimum of 150 patients will be randomly allocated to one of the three
experimental groups: control (no visit), light touch (sham acupressure) or active acupressure therapy in a 1:1:1 ratio.
Interventions will be performed three times a day for 2 days. Patient satisfaction, quality of recovery, PONV and pain
will be measured during the 3 days following randomization. The study protocol was approved by the Stony Brook
University Institutional Review Board on 21 March 2016. Written informed consent will be recorded from every
consented patient.
Discussion: This study has the potential to improve the recovery of hospitalized patients by adding knowledge
on the efficacy of acupressure therapy in this setting. A multipoint acupressure protocol will be compared to
both a no intervention group and a light touch group, providing insight into different aspects of the placebo effect.
Trial registration: ClinicalTrial.gov, NCT02762435. Registered on 14 April 2016.
Keywords: Quality of recovery, Acupressure therapy, Patient satisfaction
Background
More than 200 million major surgical procedures are
performed worldwide each year [1], and major advances
have been made to decrease postoperative morbidity and
mortality [2, 3]. These improvements in perioperative
care have allowed for the emergence of other endpoints
to assess improvement in perioperative care [4]. Patient-
rated quality of recovery [5, 6] after surgery is gaining
importance as a relevant endpoint in the study of
perioperative care.
Application of pressure to specific external sites on the
body has been practiced for hundreds of years and is gen-
erally recognized as a safe, cost-effective, non-invasive
form of therapy with few to zero adverse effects [7, 8]. A
meta-analysis studying the effectiveness of PC6 acupoint
stimulation versus sham treatment or antiemetic drugs for
the prevention of postoperative nausea and vomiting
(PONV) including 59 trials [9] found a beneficial effect for
PC6 acupoint stimulation versus sham treatment and no
differences for PC6 acupoint stimulation versus anti-
emetic. This meta-analysis recommended further high-
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quality research on PC6 acupoint stimulation and on
other acupoints. For pain treatment, a randomized
controlled trial with a sample size of 129 patients [10]
comparing acupressure and physical therapy for low back
pain treatment showed a beneficial effect on pain scores
in the acupressure group. A randomized controlled trial
by Chen et al. [11] comparing acupressure versus no acu-
pressure on sleep time and quality for intensive care unit
patients (n = 85) showed beneficial effects in the acupres-
sure group. The studied acupoints by Chen [11] were
Neiguan (PC6), Shenmen (HT7) and Yongquan (K11)
[12]. Anxiety improvement is also a studied field for acu-
pressure therapy, and Beikmoradi et al. [13] showed that
acupressure therapy including ear cavity, LI4, LI10, HT7,
LU9, DU20, Ren6, Yintang and UB13 was beneficial com-
pared to sham acupressure and control (n = 90).
Therefore, several studies suggest that acupressure
therapy may be potentially beneficial in improving post-
operative symptoms like PONV, pain and sleep disorder
and improving postoperative quality of recovery. How-
ever, high-quality evidence to show the beneficial effects
of acupressure therapy in postoperative quality of recov-
ery care is lacking. For example, in a Cochrane meta-
analysis on PONV [9], the primary outcome analysis on
PC6 acupoint stimulation and antiemetic combination
versus antiemetic alone was graded as very low quality
due to heterogeneity, limitations and imprecision among
the trials.
This three-group, parallel, superiority, blinded, ran-
domized controlled trial will test the hypothesis that
a combination of PC6, LI4 and HT7 acupressure is
superior to sham treatment or no intervention for im-
proving postoperative quality of recovery in hospital-
ized patients for surgical treatment. This therapy, if
efficient, could help in improving quality of recovery
following a large group of surgical procedures with
few potential side effects.
Methods/design
Study design
The study is a three-group, parallel, superiority, random-
ized controlled trial (Fig. 1). Participants will be postopera-
tive adult inpatients. The tested intervention will be PC6,
LI4 and HT7 acupressure therapy. The main outcome will
be quality of recovery with secondary outcome assess-
ments of patient satisfaction, PONV and pain by the third
postoperative day. The use of two comparator groups, i.e.
a sham (light touch) group and a no intervention group
Fig. 1 The Consolidated Standards of Reporting Trials (CONSORT) flow diagram template for the AcuPressure to improve Patient satisfaction and
quality of Recovery (APPROVE) study
Noll et al. Trials  (2017) 18:110 Page 2 of 7
(control group), will allow the assessment of different as-
pects of the placebo effect, including behavioural aspects
(visiting and interacting with the patient) [14]. Research
team members obtaining survey and other outcome
data will not be told the allocated group identities.
The study design aims at fulfilling the Standard
Protocol Items: Recommendations for Interventional
Trials [15] (Additional file 1: SPIRIT 2013 checklist)
and the Revised Standards for Reporting Interventions
in Clinical Trials of Acupuncture (STRICTA): extend-
ing the CONSORT Statement [16].
Setting and population
After Institutional Review Board approval, Clinical-
Trials.gov registration and written informed consent,
adult study patients will be enrolled. One hospital site
will be involved in the study reflecting homogenous
perioperative care. Only surgical patients expected to
stay at least 2 days at the hospital after surgery and able
to answer the study questions will be included. Recruit-
ing time is planned to take 4 months.
Sample size
Sample size calculations were carried out using SAS©
9.4 software, SAS, Cary, NC, USA. Based on results from
a study examining the psychometric properties of the
quality of recovery (QoR-15) evaluation [6, 17], we esti-
mate the overall change from baseline to follow-up in
untreated patients will be approximately 5% of the in-
strument total, or +7.5 points. We powered the study to
be able to detect a clinically relevant change of 10% (+15
points) in the treatment group, with a standard deviation
of 12 points. The primary hypothesis is a better quality
of recovery in patients randomized to the active acupres-
sure intervention group. A sample size of 50 subjects
per arm (150 total) was calculated based on a two-
sample t test for mean difference, with power = 0.85,
alpha = 0.05. We have requested a total of 200 patients
consented in order to allow for some screen failures that
will inevitably occur, e.g. cancelled surgery.
Recruitment
Patients will be screened at an academic center, the Stony
Brook Medicine Hospital (Stony Brook, NY, USA) by a
research team member. Those meeting all the inclusion
criteria and none of the exclusion criteria will be intro-
duced to the study. If interested, patients will be provided
with complete information about the study including
explanation, information sheet and clarification of any
questions. Contact information for future questions will
be provided and written informed consent recorded.
Inclusion criteria are English-speaking patients at Stony
Brook Medicine Hospital who are expected to stay in the
hospital for at least 2 days and are able to provide written
informed consent.
Exclusion criteria are as follows: patients younger than
18 years of age; those who do not have access to the
three points on the hand and wrist due to skin break-
down, ulcers, cellulitis, broken bone, indwelling catheter
within 5 cm radius of the pressure points, etc. (since the
plan is to apply the pressure unilaterally, this exclusion
only applies if the issue that is preventing pressure to be
applied exists on both extremities); significant dementia
or altered mental status that would prevent assessment
of the QoR-15 survey; allergic reaction to ink from a
Sharpie pen; stroke or other neurologic condition which
precludes sensation in both upper extremities; use of re-
gional anaesthetic technique, e.g. epidural, continuous
peripheral nerve catheter, after postoperative day 1 at 12
noon; women who are currently pregnant, screened via
urine pregnancy test.
Randomization and allocation concealment
Randomization will be performed using a sealed envelope
technique. Envelopes will not be reused in any case.
Patients will be randomly allocated to one of the three ex-
perimental groups (Figs. 1 and 2): control (no visit), light
touch (sham acupressure) or active acupressure therapy.
A 1:1:1 ratio computer-generated randomization schema
stratified on the use of postoperative regional anaesthesia
in random permuted blocks of varying sizes will be
STUDY PERIOD
Enrolment Allocation Post-allocation Close-out















[QoR-15 Score] X X
[PONV] X X X X
[Pain] X X X X
[Patient 
Satisfaction] X
Fig. 2 APPROVE study schedule of enrolment, interventions
and assessments
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provided by the trial’s statistician. To keep the statistician
blinded to the study groups, the statistician will provide
the randomization schemes in an A/B/C format; an inde-
pendent individual not otherwise involved in the study will
finalize the assignment of the actual treatment arm and
prepare the sealed envelopes. Each participant will be ran-
domized (i.e. envelope opened) before the first interven-
tion but after marking of the three acupoints with a
Sharpie pen by research team members (including SS,
CM, EN).
Process to ensure blinding
Patients, routine care providers and team members per-
forming outcome assessment visits will not be told of
the patients’ study group allocation. Allocation will only
be revealed on request from routine care providers if ne-
cessary to change the management of the patient. All
other team members (including SS, CM, EN) will apply
the active/light touch interventions. Study acupoints will
be marked on all patients to ensure assessor blinding.
Intervention
Acupoints will be marked on every patient before
randomization using a Sharpie pen. As recommended by
experts [18], the first choice side is left for males and
right for females
In the active intervention group, acupressure therapy
will consist of unilateral thumb pressure application on
the following acupoints [12]: PC6 for 2 minutes, then
approximately 1 minute rest, then LI4 for 2 minutes,
then approximately 1 minute rest, and then HT7 for 2
minutes. PC6 is two patient interphalangeal thumbs
width proximal to the anterior wrist crease between the
flexor carpi radialis and palmaris longus, LI4 is at the
center between the 1st and 2nd metacarpal bones and
HT7 anterior wrist crease, proximal to the pisiform and
lateral to the flexor carpi ulnaris tendon [12] (Fig. 3).
Acupressure involves a very strong level of pressure,
which is often just below the level that elicits pain,
whereas the light touch group is merely touched, with
no significant pressure involved. Research team mem-
bers performing interventions will be trained to perform
a standardized pressure defined by an expert acupressure
therapist (XG) using high frequency feedback simulation.
High frequency feedback consists of a training plan
based on practicing to apply pressure on a weighting
scale to mimic the expert pressure values. The trainees
were given feedback on the applied pressure at high fre-
quency (every minute). In our training program for
study personnel we used a scale to show how much
pressure should be used for acupressure (approximately
5000 g) vs. light touch (approximately 50 g), which rep-
resents a 100-fold difference in level of pressure. Using
weighting scale-based simulation training for pressure
application has already been validated for cricoid pres-
sure training [19].
In the light touch group, intervention will consist of
the thumb lightly touching the same acupoints, dur-
ing the same time and in the same order as the
acupressure group. Research team members will also
be trained to perform standardized light touch de-
fined by an expert acupressure therapist (XG) using
high frequency feedback simulation. Both the acupres-
sure and light touch procedures will follow the same
standardized procedural protocol.
The interventions (acupressure or light touch) will
start at the first postoperative day in the morning after
randomization has occurred (day 0) and end on study
Fig. 3 PC6, LI4 and HT7 acupoint locations. The acupoints are represented by the applied thumb position
Noll et al. Trials  (2017) 18:110 Page 4 of 7
day 2 in the evening. Interventions will be performed
three times a day: between 7:00 to 10:00 am, 12 noon to
2:00 pm and 5:00 to 7:00 pm.
In the control group, no visit will be performed except
for the endpoints assessment.
Interventions will be terminated only on patient
request or if an exclusion criterion later occurs.
Concurrent treatment
All patients will receive routine care. To assess balance be-
tween the three groups in potential confounders, variables
such as age, sex, comorbidities, type of surgery, type of
anaesthesia, type of anaesthetic agents, prophylactic
antiemetics and sleep aids will be recorded. Clinicians in-
volved in routine patient care will be blinded to study
group assignment.
Outcome measures
Data will be collected using an electronic case report
form and a few written forms created to maintain blind-
ing of the assessors. The primary endpoint will be the
change in the established quality of recovery (QoR)-15
score [6]. The QoR-15 is a 15-question survey measuring
patient satisfaction/quality of recovery including pain,
nausea, sleep and well-being. Each question is rated on a
Likert scale from 0 to 10. The maximum score of the
QoR-15 is 150 points, indicating ideal health status. This
score will be assessed by a research team member on
study day 0 between 7:30 and 8:30 am prior to first
intervention and on study day 3 between 7:00 and
10:00 am. If the patient is discharged from the
hospital before study day 3, the QoR-15 score will be
completed by telephone.
Secondary endpoints include individual measures of
pain, nausea and patient satisfaction, using a numeric
rating scale, and vomiting that will be assessed on study
days 0 (between 7:30 and 8:30 am, i.e. before the first
intervention), 1 and 2 (between 3:00 and 4:00 pm).
Patient opinion about acupressure effect will be assessed
on study day 0 between 7:30 and 8:30 am prior to
the first intervention and on study day 2 between
7:00 and 10:00 am.
Other secondary endpoints will be recorded daily from
the patient medical record, including sleep aids, anti-
emetic administration, opioid and non-opioid consump-
tion, episodes of delirium and hospital length of stay. A
research coordinator will monitor accuracy of the data
in randomly sampled case report forms by comparing
hospital source documents with data in the electronic
case report form. QoR-15 scores will be recorded on
paper case report forms and later entered into an MS
Access© database. Study documents will be stored in a
locked cabinet. Study team members will have access to
the final trial dataset.
Data analysis
Analysis plan
This is a randomized, single-blinded controlled trial. The
study will be analysed in four ways. The primary method
of analysis will use the modified intention to treat
(mITT) approach, with the treatment group incurring at
least one treatment session. Patients who obtain the
baseline measurement and are randomized to the treat-
ment group but do not receive at least one treatment
will be excluded from the analysis. Otherwise, missing
data will be accounted for using a multiple imputations
method [20]. In addition, if data are missing at random,
a secondary sensitivity analysis will be conducted that
excludes patients with missing follow-up data, but
includes patients who did not complete the entire treat-
ment regimen (follow-up complete, FC). A tertiary
adherers-only (AO) analysis may be included to examine
the subset of patients who fully received the treatment
to which they were randomized and completed both
baseline and follow-up assessments. We will also
perform an ITT analysis.
Statistical analysis
The primary outcome of this study is the QoR-15
change score from baseline to follow-up on day 3. Mean
change score between the control group (no interven-
tion) and the acupressure treatment group will be
assessed for differences using either the Student’s t test
or Wilcoxon rank sum test. We do not expect to see any
significant differences between the two groups regarding
age, sex, American Society of Anesthesiologists (ASA)
status, surgical duration, anaesthetic technique, intraoper-
ative fluid therapy volume, postoperative day 1 Sequential
Organ Failure Assessment Score [21] and other comorbid-
ities due to the randomization process; however, we will
examine the groups for differences. Additional event met-
rics (e.g. antiemetic medication consumption and opioid
consumption (including amount)) during the study
period will also be collected and analysed. Event vari-
ables that differ significantly between groups may be
used as potential covariates in a multivariate linear
regression. The statistician will remain blinded to the
group assignment for the analyses.
Finally, for all four methods of analysis (mITT, FC,
AO, ITT), secondary assessments for the placebo effect
will be conducted. Analyses for differences in mean
change QoR-15 score include comparisons between (1)
the control vs. sham group and (2) the sham group vs.
the active acupressure group.
Discussion
Acupressure intervention
We selected three acupoint locations, based on recom-
mendations by the World Health Organisation [12].
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These points are commonly used for treating symptoms
that may improve quality of recovery like PONV, pain and
sleep disturbance. These acupoint locations will be
marked accordingly on every patient before randomization
to improve the standardization of the intervention and
decrease the hazard of measurement bias.
Multipoint acupressure [22–25] was preferred over
single point acupressure to increase the likelihood of
triggering a beneficial signal. The combination of
multiple acupressure points was shown to be benefi-
cial for ventilator-induced anxiety and dyspnoea [22],
for prehospital analgesia in patients with radial frac-
tures [25] and for prehospital analgesia in patients
with minor trauma [26].
We chose to apply acupressure for 2 minutes on each
point at each session. This duration has already been used
in published randomized controlled trials reporting bene-
ficial effects of acupressure therapy. Wang and colleagues
reported beneficial effects on self-assessed quality of life
for hemodialysed patients [27] using 2 minutes of pressure
on auricular acupoints. Similary, Pouresmail described
positive effects of 2 minutes of acupressure on primary
dysmenorrhea [28]. Yang et al. [29] reported favourable
effects of 2 minutes per point acupressure associated with
aromatherapy on dementia-associated agitation.
The frequency of the intervention was set as three times
a day, similar to previously published studies, including
those of Chang et al. for postoperative pain after total knee
replacement [30] and Shin et al. for hyperemesis gravi-
darum [31].
The treatment will be administered for 2 days, which was
a balance between more sessions (i.e. 6 days) that might
confer more benefit with a need to limit the sessions to a
period of time when these hospitalized patients would still
be available for the study interventions.
Outcome measurements
This trial aims at assessing the effectiveness of acupressure
therapy on quality of recovery and patient satisfaction in
hospitalized patients. The QoR-15 score was developed to
determine a self-rated patient measure of overall health
status [6] and has undergone psychometric and external
validation [17]. The QoR-15 score is easy to administer
and has been validated to detect clinically important
differences in patient-perceived health status [32]. There-
fore, we believe it is a relevant endpoint for assessing
acupressure therapy effectiveness in this setting.
Control groups
Control groups are very challenging to define when study-
ing complex non-pharmacological therapies like acupres-
sure. Control group treatments may consist of standard
care without any additional intervention, moderate pressure
on a sham acupoint or light touch on a real acupoint. Each
of these controls may explore another aspect of the placebo
effect being part of the acupressure therapy [14]. In this
study we choose two control groups: no intervention at
all and light touch on the real acupoints (type 3 sham
methods according to the Tan classification [14]). This
will allow us to explore the contribution of the placebo
effect induced by direct human contact and interaction
in the light touch group.
Trial Status
Screening began on 28 March 2016.
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